The New FDA: Product Development, Pricing and Beyond
Dec 20, 2016•6 min
Episode description
What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.
For the best experience, listen in Metacast app for iOS or Android
